These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7529632)

  • 21. Inhibitory effect of angiogenesis inhibitor TNP-470 on human ACHN renal cell carcinoma.
    Zeng J; Mei W; Huang H; Li X; Kong P
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(4):331-3. PubMed ID: 12674772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor effect of the angiogenesis inhibitor TNP-470 on human digestive organ malignancy.
    Konno H
    Cancer Chemother Pharmacol; 1999; 43 Suppl():S85-9. PubMed ID: 10357565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
    Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S
    J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of angiogenesis inhibitor TNP-470 on the progression of human gastric cancer xenotransplanted into nude mice.
    Kanai T; Konno H; Tanaka T; Matsumoto K; Baba M; Nakamura S; Baba S
    Int J Cancer; 1997 May; 71(5):838-41. PubMed ID: 9180154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic potential of the anti-angiogenesis drug TNP-470.
    Gervaz P; Fontolliet C
    Int J Exp Pathol; 1998 Dec; 79(6):359-62. PubMed ID: 10319017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenesis inhibitor TNP-470 inhibits growth and metastasis of a hormone-independent rat prostatic carcinoma cell line.
    Miki T; Nonomura N; Nozawa M; Harada Y; Nishimura K; Kojima Y; Takahara S; Okuyama A
    J Urol; 1998 Jul; 160(1):210-3. PubMed ID: 9628652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model.
    Drevs J; Hofmann I; Hugenschmidt H; Wittig C; Madjar H; Müller M; Wood J; Martiny-Baron G; Unger C; Marmé D
    Cancer Res; 2000 Sep; 60(17):4819-24. PubMed ID: 10987292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer.
    Konno H; Tanaka T; Matsuda I; Kanai T; Maruo Y; Nishino N; Nakamura S; Baba S
    Int J Cancer; 1995 Apr; 61(2):268-71. PubMed ID: 7535757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TNP-470 is an effective antimicrosporidial agent.
    Coyle C; Kent M; Tanowitz HB; Wittner M; Weiss LM
    J Infect Dis; 1998 Feb; 177(2):515-8. PubMed ID: 9466552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).
    Yamaoka M; Yamamoto T; Masaki T; Ikeyama S; Sudo K; Fujita T
    Cancer Res; 1993 Sep; 53(18):4262-7. PubMed ID: 7689930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TNP-470 antiangiogenic therapy for advanced murine neuroblastoma.
    Nagabuchi E; VanderKolk WE; Une Y; Ziegler MM
    J Pediatr Surg; 1997 Feb; 32(2):287-93. PubMed ID: 9044139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of tumor growth and downregulation of platelet-derived endothelial cell growth factor / thymidine phosphorylase in tumor cells by angiogenesis inhibitor TNP-470.
    Mori J; Haisa M; Naomoto Y; Takaoka M; Kimura M; Yamatsuji T; Notohara K; Tanaka N
    Jpn J Cancer Res; 2000 Jun; 91(6):643-50. PubMed ID: 10874218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic effects of the angiogenesis inhibitor TNP-470 against carcinomatous peritonitis in mice.
    Tsujimoto H; Hagiwara A; Osaki K; Ohyama T; Sakakibara T; Sakuyama A; Ohgaki M; Imanishi T; Watanabe N; Yamazaki J
    Anticancer Drugs; 1995 Jun; 6(3):438-42. PubMed ID: 7545480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines.
    Yamaoka M; Yamamoto T; Ikeyama S; Sudo K; Fujita T
    Cancer Res; 1993 Nov; 53(21):5233-6. PubMed ID: 7693335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic efficacy of the angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) for human anaplastic thyroid carcinoma in nude mice.
    Hama Y; Shimizu T; Hosaka S; Sugenoya A; Usuda N
    Exp Toxicol Pathol; 1997 Aug; 49(3-4):239-47. PubMed ID: 9314059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumour effects of the angiogenesis inhibitor AGM-1470 on rat urinary bladder tumours induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Osawa S; Terashima Y; Kimura G; Akimoto M
    BJU Int; 1999 Jan; 83(1):123-8. PubMed ID: 10233464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2.
    Mori S; Yoshikawa H; Hashimoto J; Ueda T; Funai H; Kato M; Takaoka K
    Bone; 1998 Feb; 22(2):99-105. PubMed ID: 9477232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
    Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
    Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNP-470 inhibits collateralization to complement the anti-tumour effect of hepatic artery ligation.
    Mugitani T; Taniguchi H; Takada A; Yamaguchi A; Masuyama M; Hoshima M; Takahashi T
    Br J Cancer; 1998 Feb; 77(4):638-42. PubMed ID: 9484823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of murine angiosarcoma with etoposide, TNP-470 and prednisolone.
    Ma G; Masuzawa M; Hamada Y; Haraguchi F; Tamauchi H; Sakurai Y; Fujimura T; Katsuoka K
    J Dermatol Sci; 2000 Nov; 24(2):126-33. PubMed ID: 11064248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.